KKKousuke Kanemoto

Kousuke Kanemoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kousuke Kanemoto has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Depression in people with epilepsy: How much do Asian colleagues acknowledge it?

    by Ali A. Asadi-Pooya, Kousuke Kanemoto, Oh-Young Kwon, Go Taniguchi, Zhou Dong, Yotin Chinvarun, Hsiang-Yu Yu, Aileen McGonigal, Andres Miguel Kanner, Sung-Pa Park


  • Open Access

    PNES around the world: Where we are now and how we can close the diagnosis and treatment gaps—an ILAE PNES Task Force report

    by Kousuke Kanemoto, W. Curt LaFrance, Roderick Duncan, David Gigineishvili, Sung‐Pa Park, Yukari Tadokoro, Hiroko Ikeda, Ravi Paul, Dong Zhou, Go Taniguchi, et al.

    Summary: An international consensus clinical practice statement issued in 2011 ranked psychogenic nonepileptic seizures (PNES) among the top three neuropsychiatric problems. An ILAE PNES Task Force was founded and initially charged with summarizing the current state of the art in terms of diagnosis and treatment, resulting in two publications. The first described different levels of diagnostic certainty. The second summarized current knowledge of management approaches. The present paper summarizes an international workshop of the ILAE PNES Task Force that focused on the current understanding and management of PNES around the world. We initially provide a knowledge update about the etiology, epidemiology, and prognosis of PNES—in adults and in special patient groups, such as children, older adults, and those with intellectual disability. We then explore clinical management pathways and obstacles to optimal care for this disorder around the world by focusing on a number of countries with different cultural backgrounds and at very different stages of social and economic development (United Kingdom, U.S.A., Zambia, Georgia, China, and Japan). Although evidence‐based methods for the diagnosis and treatment of PNES have now been described, and much is known about the biopsychosocial underpinnings of this disorder, this paper describes gaps in care (not only in less developed countries) that result in patients with PNES not having adequate access to healthcare provisions. A range of challenges requiring solutions tailored to different healthcare systems emerges. Continued attention to PNES by the ILAE and other national and international neurologic, psychiatric, and health organizations, along with ongoing international collaboration, should ensure that patients with PNES do not lose out as healthcare services evolve around the world.


  • Delusional experience awareness gap between patients and treating doctors — Self-reported EPDS questionnaire

    by Kousuke Kanemoto, Hisamitsu Tsuda, Hiroko Goji, Yukari Tadokoro, Tomohiro Oshima, Hisateru Tachimori, Bertrand DeToffol


  • Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China

    by Xin Tong, Dongmei An, Lili Lan, Xiaobo Zhou, Qin Zhang, Fenglai Xiao, Sung-Pa Park, Kousuke Kanemoto, Andres M. Kanner, Dong Zhou


  • Lack of Data on Depression-like States and Antidepressant Pharmacotherapy in Patients with Epilepsy: Randomised Controlled Trials are Badly Needed

    by Kousuke Kanemoto, Yukari Tadokoro, Abigail J. Sheldrick, Tomohiro Oshima

    The prevalence of depression in patients with epilepsy (PWE) is high. To elucidate the nature of depression in PWE, a comparison was made between PWE and patients with idiopathic depression (PWID), applying 3 test batteries: Beck Depression Inventory II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D) and Buss–Perry Aggression Questionnaire (BAQ). The former 2 rating scales were developed to measure depressive symptoms, while the latter was designed to detect anger and aggressive states. As a result, the group of patients with PWE showed significantly higher BAQ scores in comparison to those with PWID. Further, the BAQ and BDI scores were closely related within a group of PWE, while BAQ and BDI scores were not correlated with each other within a group of PWID. With regard to pharmaceutical therapy, the safety of antidepressants, especially SSRIs, is well established. However, there has been only one randomized controlled trial (RCT) thus far, which failed to show a significant difference in efficacy between placebo and various antidepressants. In contrast, there are two RCTs regarding the efficacy of LTG. The clinical profile of the depressiolytic effects of LTG in PWE may be different from that of antidepressants in patients with idiopathic depression, in that BAQ is more sensitive measure than BDI or CES-D. It is now widely recognized that the failure to treat depression in PWE can result in serious consequences. However, even a fundamental question, such as whether antidepressants are as effective in this population as in PWID, remains to be answered.


  • Open Access

    Psychotic illness in patients with epilepsy

    by Kousuke Kanemoto, Yukari Tadokoro, Tomohiro Oshima

    Apart from the rather rare ictal psychotic events, such as non-convulsive status epilepticus, modern epileptic psychoses have been categorized into three main types; chronic and acute interictal psychoses (IIPs) and postictal psychosis (PIP). Together, they comprise 95% of psychoses in patients with epilepsy (PWE). Four major questions, that is, “Is psychosis in PWE a direct consequence of epilepsy or schizophrenia induced by epilepsy?”, “Is psychosis in PWE homogeneous or heterogeneous?”, “Does psychosis in PWE have symptomatological differences from schizophrenia and related disorders?”, “Is psychosis in PWE uniquely associated with temporal lobe epilepsy (TLE)?” are tried to be answered in this review with relevant case presentations. In the final section, we propose a tentative classification of psychotic illness in PWE, with special attention to those who have undergone epilepsy surgery. Psychotic disorders in PWE are often overlooked, mistreated, and consequently lingering on needlessly. While early diagnosis is unanimously supported as a first step to avoid this delay, necessity of switching from antiepileptic drugs with supposedly adverse psychotopic effects. to others is more controversial. To elucidate the riddle of alternative psychosis, we need badly further reliable data.


  • The Neuropsychiatry of Epilepsy

    by Michael R. Trimble, Bettina Schmitz, Albert P. Aldenkamp, Fizzah Ali BMedSc, Frank M.C. Besag, Penny Blake, Sarah Broicher, Andrea Eugenio Cavanna, Thierry Deonna, Marie-Aline Eden, et al.

    Research into the neuropsychiatry of epilepsy has become a central focus of interest in the last five years. Comorbidity of epilepsy with behavioral problems is now recognized widely, and the neuroscientific basis for such comorbidity is an active area of investigation. With an expanded international team of authors, this fully revised new edition builds on the strengths of its predecessor, examining in detail the subtleties of behavioral changes in patients with seizure disorders and offering both a diagnostic and a management perspective. New chapters cover genetic disorders, the effects of epilepsy on social behavior as viewed through theory of mind, a discussion of the precuneus, the importance and nature of peri-ictal psychiatric symptoms, depression and the interictal dysphoric disorder, and the relationship between antiepileptic drugs and suicide. This new edition is a must for anyone involved in diagnosing or managing epilepsy.


  • Open Access

    Increased Frequency of Interleukin‐1β‐511T Allele in Patients with Temporal Lobe Epilepsy, Hippocampal Sclerosis, and Prolonged Febrile Convulsion

    by Kousuke Kanemoto, Jun Kawasaki, Shoji Yuasa, Testuo Kumaki, Oshima Tomohiro, Ryuji Kaji, Masataka Nishimura

    Summary:  Purpose: To confirm the high frequency of interleukin (IL)‐1β‐511T allele occurrence in patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS), with special attention given to the impact of prolonged febrile convulsions (PFCs) on IL‐1β genotype distribution. Methods: Patients with evidence of unilateral HS on magnetic resonance (MR) images were chosen as study subjects (TLE+HS; n = 66). Other patients with essentially normal MRI findings or only foreign tissue (TLE without HS; TLE‐HS; n = 64), and those with symptomatic localization‐related epilepsy but without TLE (SLE; n = 89) were selected as disease controls. A single base pair polymorphism at position 2511 in the promoter region of the IL‐1β gene was analyzed. Results: The distribution of IL‐1β‐511 genotypes as well as allele frequency was significantly different between TLE+HS patients and controls. In contrast, no difference was found between TLE‐HS patients and controls or between SLE patients and controls. Further, in the group of patients with TLE+HS, the frequency of the IL‐1β‐511T allele tended to increase as a function of febrile convulsions [0.531 without either PFC or simple febrile convulsion (SFC); 0.633 with SFC; 0.686 with PFC]. Although no statistically significant difference was noted between patients without PFC and the controls, a χ2 analysis of allele distribution revealed a significant difference between those with PFC and the controls. Conclusions: PFC proved to be a potent determinant of IL‐1β‐511T allele frequency; thus a discrepancy of PFC incidence should be considered an explanation of recent conflicting results regarding the association between the gene polymorphisms of IL‐1β‐511 and TLE+HS.